17,022 Shares in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Bought by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC bought a new stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 17,022 shares of the real estate investment trust's stock, valued at approximately $298,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Jones Financial Companies Lllp increased its position in shares of Sabra Healthcare REIT by 208.3% during the fourth quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust's stock worth $108,000 after buying an additional 4,204 shares during the period. Assetmark Inc. grew its holdings in Sabra Healthcare REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust's stock worth $45,000 after acquiring an additional 656 shares during the period. Atria Investments Inc grew its holdings in Sabra Healthcare REIT by 5.3% during the 4th quarter. Atria Investments Inc now owns 33,349 shares of the real estate investment trust's stock worth $578,000 after acquiring an additional 1,686 shares during the period. Arizona State Retirement System raised its position in shares of Sabra Healthcare REIT by 1.9% in the 4th quarter. Arizona State Retirement System now owns 67,951 shares of the real estate investment trust's stock worth $1,177,000 after acquiring an additional 1,293 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of Sabra Healthcare REIT in the 4th quarter valued at about $887,000. Institutional investors and hedge funds own 99.40% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on SBRA. Truist Financial lifted their target price on Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, March 18th. Scotiabank lifted their price objective on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $19.67.

Sabra Healthcare REIT Stock Up 0.5%

Sabra Healthcare REIT stock traded up $0.09 during mid-day trading on Friday, reaching $18.46. The stock had a trading volume of 3,639,191 shares, compared to its average volume of 2,308,133. The firm has a market capitalization of $4.39 billion, a PE ratio of 31.29, a price-to-earnings-growth ratio of 1.53 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The stock's 50-day simple moving average is $18.00 and its 200-day simple moving average is $17.37. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.22 and a current ratio of 4.22.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The real estate investment trust reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.01. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The business had revenue of $183.54 million during the quarter, compared to the consensus estimate of $180.23 million. During the same quarter last year, the firm posted $0.35 EPS. Sabra Healthcare REIT's revenue was up 10.1% compared to the same quarter last year. On average, sell-side analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 30th. Investors of record on Friday, May 16th were issued a $0.30 dividend. The ex-dividend date was Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.50%. Sabra Healthcare REIT's dividend payout ratio is presently 203.39%.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the completion of the sale, the director directly owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.20% of the company's stock.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.